The briefing
News Medical highlights PROMISE III trial data indicating that transcatheter arterialization of the deep veins improved quality of life for chronic limb‑threatening ischemia patients lacking other treatment options. Investigators observed significant patient‑reported gains after the procedure.
Original headline
Transcatheter arterialization of the deep veins improves quality of life for no-option CLTI patients